Carlo Catapano
http://usi.to/2fc
Progetti
In corso (1)
Conclusi (12)
- Geiger R., Catapano C., Cejka P., Sallusto F., Theurillat J. P. (2022) timsTOF Pro 2 for clinical proteomics
- Catapano C. (2020) Nanoparticle-based delivery and combinatorial therapies for cancer
- Alimonti A., Calcinotto A., Catapano C., Iezzi G., Rossi D. (2019) High parameter cell analysis by BD FACSymphony
- Catapano C. (2017) Targeting metabolic reprogramming and plasticity of cancer stem cells to impact on tumor progression and treatment resistance
- Catapano C. (2017) Epigenetic cross-talks and novel therapeutic strategies to prevent disease progression in ERG fusion positive prostate cancer
- Varani L., Catapano C., Cavalli A., Lanzavecchia A., Thelen M., Uguccioni M. (2015) Acquisition of a 600MHz solution NMR spectrometer
- Catapano C., Carbone G. (2014) Promoter-proximal long non-coding RNAs and epigenetic regulatory networks in prostate cancer
- Lanzavecchia A., Catapano C., Thelen M., Uguccioni M., Varani L. (2010) Analysis of the human immune response using high-throughput cellular screening
- Catapano C. (2010) DENANORNA - Dendrimers as nanovectors for targeted siRNA delivery in gene therapy
- Catapano C. (2009) Small RNA-based transcriptional control of cancer genes
- Carbone G., Bertoni F., Catapano C. (2007) The epithelial specific ETS transcription factor-3 as a tumor suppressor in prostate cancer
- Catapano C. (2006) Gene selective transcriptional repression by antigene oligonucleotides
